Sonoco Products Company (SON) — Fair Value Analysis

Base-case fair value (P50): $51.09 · Current price: $58.02 · Verdict: Fairly Valued

The Verdict on SON

Based on Monte Carlo simulations, SONOCO PRODUCTS (SON) is currently assessed as Fairly Valued. The analysis indicates a median fair value (P50) of $51.09, standing against the current market price of $58.02. This suggests an -11.9% difference, confirming the "Fairly Valued" assessment rather than a significant overvaluation or undervaluation. Investors should note this tight alignment between the current trading level and the probability-weighted intrinsic value. While SON is not presenting an obvious bargain or premium based on this metric, the fair value derived from thousands of forward-looking scenarios provides a robust benchmark for its current trading behavior. The weak quality tier for SONOCO PRODUCTS reinforces the need for careful consideration despite the neutral valuation.

How SON stacks up against peers

SONOCO PRODUCTS exhibits a weak quality tier when evaluating its operational and financial health against its sector. This classification is a critical overlay to the "Fairly Valued" assessment for SON. Despite a median fair value of $51.09 closely aligning with its $58.02, the underlying quality tier suggests potential vulnerabilities or inefficiencies relative to industry benchmarks. This means that while the market price of $58.02 is not signaling an immediate mispricing against our P50, the company's relative fundamental strength should be a key consideration. The weak quality tier provides context for the valuation, advising caution as the market prices in the current fundamentals, resulting in the -11.9% gap.

What this means for investors

For investors considering SONOCO PRODUCTS (SON), the Monte Carlo simulations indicate a "Fairly Valued" status. With the current price of $58.02 holding an -11.9% difference against our median fair value of $51.09, the analysis suggests little immediate alpha opportunity from a pure valuation perspective. The weak quality tier further tempers expectations, highlighting that while the stock is not overvalued, its fundamental health relative to the sector warrants scrutiny. Investors should interpret the narrow gap between $58.02 and $51.09 as the market accurately reflecting SON's current standing, especially given its operational context. FairCurve's detailed analysis allows for deeper understanding beyond just the median. To see the full bear and bull distribution and track SON's fair value as new fundamentals are released, sign up for a free FairCurve account.